Abstract

Summary

Night shift work suppresses melatonin production through light-at-night exposure detected by ipRGCs, disrupting circadian rhythmicity and potentially increasing breast cancer risk, particularly with age. Lighting designers in healthcare and workplace settings should consider minimizing short-wavelength (blue) light exposure during night shifts to preserve melatonin secretion and reduce associated health risks.
Abstract

Key Findings

  • Night shift work is associated with increased breast cancer risk, with melatonin suppression by artificial light at night proposed as a key biological mechanism.
  • ipRGCs containing melanopsin are the primary photoreceptors mediating circadian light input to the SCN, driving melatonin suppression.
  • Age-related decline in melatonin production compounds the effects of night shift-induced suppression, potentially elevating cancer risk in older shift workers.
Categories

Categories

Shift Work & Staff Wellbeing: Examines how night shift work disrupts melatonin production and circadian rhythms, with implications for breast cancer risk.
Sleep & Circadian Health: Discusses circadian rhythm disruption, melatonin suppression by light at night, and SCN-mediated photoentrainment via ipRGCs.
The Science of Light: Covers ipRGC-mediated light sensing, SCN clock gene interactions, and the biological mechanisms linking light exposure to melatonin suppression.
Authors

Author(s)

A Engin, AB Engin
Publication Date

Publication Year

2015
View more publications